Rite Aid Cites 'lack Of Credibility' To Reject Spear Point Capital's Acquisition Proposal

Rite Aid Corporation (RAD), a drug store chain, on Thursday confirmed that it previously rejected a non-binding, off-market proposal from Spear Point Capital Management to buy all of its shares.

Following an elaborated review, Board concluded saying "the proposal was not credible and did not warrant further exploration."

The store chain noted that Spear Point's proposal provided no evidence of financing, required multiple months of exclusivity and then called for Rite Aid to spend months soliciting competing offers.

In addition, the company said, Spear Point has no track record of acquiring public companies the size and complexity of Rite Aid.

Commenting on its future plans, Rite Aid said it will be responsive to all credible proposals that will enhance stockholder value.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT